Treatment for Laryngitis
Do not routinely prescribe antibiotics for laryngitis, as acute laryngitis is typically viral and self-limited, resolving within 7-10 days without antibiotic treatment 1.
Acute Laryngitis Management
Primary Treatment Approach
The cornerstone of acute laryngitis management is supportive care and symptom management, not antimicrobial therapy. The 2018 American Academy of Otolaryngology guidelines provide a strong recommendation against routine antibiotic use, based on systematic reviews and randomized trials demonstrating ineffectiveness and a preponderance of harm over benefit 1.
Why Antibiotics Don't Work
- Acute laryngitis is caused by viral pathogens (parainfluenza, rhinovirus, influenza, adenovirus)
- A Cochrane review found antibiotics do not improve objective voice outcomes 2
- While erythromycin showed modest subjective improvements (reduced voice disturbance at 1 week, reduced cough at 2 weeks), these benefits do not outweigh costs, adverse effects, and contribution to antibiotic resistance 2
- Natural history: symptoms improve within 7-10 days regardless of treatment 1
Corticosteroids: Use With Extreme Caution
Steroids should not be used empirically 1. The guideline explicitly states that due to significant risk profiles and limited evidence of benefit, corticosteroids should only be considered when:
- The specific diagnosis is known and treatment is targeted
- Shared decision-making occurs with the patient
- Risks and limited evidence for benefit have been thoroughly discussed
- Professional voice users may warrant special consideration
When Antibiotics MAY Be Appropriate
Antibiotics are reserved for select circumstances only 1:
- Immunosuppressed patients
- Documented bacterial superinfection
- Specific conditions like laryngeal tuberculosis in transplant patients
Chronic Laryngitis Considerations
For chronic laryngitis (>3 weeks duration), the approach differs:
Identify and Address Underlying Causes
- Gastroesophageal reflux: Nocturnal antireflux precautions and acid-suppressing medications 3
- Irritant exposure: Tobacco cessation (present in 72.7% of chronic cases) 4
- Autoimmune disorders: May warrant targeted corticosteroid therapy for conditions like lupus, sarcoidosis, or granulomatosis with polyangiitis 1
Chronic Bacterial Laryngitis (CBL)
Recent evidence shows CBL is challenging to diagnose and treat 5:
- Common pathogens: MSSA (40.3%), MRSA (25.6%), Klebsiella (33.3%)
- Complete resolution occurs in only 9.5-48.6% of patients
- High retreatment rates (38-50.2%) and recurrence (32%)
- Diabetes associated with higher retreatment likelihood
- No standardized diagnostic or treatment guidelines exist
Critical Pitfalls to Avoid
Reflexive antibiotic prescribing: Exposes patients to unnecessary costs (antibiotics account for 30% of medication costs in laryngeal disorders), side effects (rash, GI symptoms), and drug interactions 1
Contributing to antibiotic resistance: Overprescription has led to increasing MRSA rates in respiratory infections, with 33% higher treatment costs in regions with higher resistance 1
Empiric steroid use: Significant risks include candidiasis, pharyngitis (dose-dependent), avascular necrosis, pancreatitis, and diabetogenesis 1
Missing reflux laryngitis: Chronic symptoms often respond to acid suppression rather than antibiotics 3